SCHEMBL1894003

SCHEMBL1894003

N#Cc1ccc(S([O])(=O)=O)cc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 7/20 0.57
▸ CA1 P00915 6/20 0.57
▸ CA9 Q16790 4/20 0.57
▸ CA12 O43570 3/20 0.57
▸ CYP19A1 P11511 2/20 0.50
▸ MAOA P21397 2/20 0.46
▸ MAOB P27338 2/20 0.46
▸ IDO1 P14902 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP2A6 P11509 1/20 0.44
▸ CA3 P07451 1/20 0.44
▸ CA6 P23280 1/20 0.44
▸ CA14 Q9ULX7 1/20 0.44
▸ BCHE P06276 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ KDM1A O60341 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8514633 0.82 CA2 (0.59) CA2CA1CA9CA12CYP19A1
SCHEMBL1332778 0.80 CA2 (0.57) CA2CA1CA9CA12CYP19A1
SCHEMBL61854 0.78 CA1 (0.55) CA2CA1CA9CA12CYP19A1
SCHEMBL28445682 0.78 CA2 (0.55) CA2CA1CA9CA12CYP19A1
SCHEMBL28216092 0.78 CA2 (0.55) CA2CA1CA9CA12CYP19A1
Silver SCHEMBL4326545 0.78 CA2 (0.55) CA2CA1CA9CA12CYP19A1
SCHEMBL803901 0.78 PTGS2 (0.68) CA2CA1CA9CA12CYP19A1
SCHEMBL1894004 0.78 CA2 (0.55) CA2CA1CA9CA12CYP19A1
SCHEMBL8779787 0.78 CA2 (0.55) CA2CA1CA9CA12CYP19A1
SCHEMBL329973 0.78 CA2 (0.88) CA2CA1CA9CA12MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140012032-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS PIRAMAL IMAGING SA (CH) 2014-01-09 — — US claimed
CN-103328012-A Method for production of f-18 labeled amyloid beta ligands Bayer Pharma AG 2013-09-25 — — CN claimed
EP-2575900-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS Piramal Imaging SA (CH) 2013-04-10 — — EP claimed
WO-2011151281-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-08 — — WO claimed
EP-2575898-B1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGAND LIFE MOLECULAR IMAGING SA (CH) 2020-09-30 — — EP disclosed
CN-105849638-B Active light-sensitive or radiation-sensitive resin composition and film 富士胶片株式会社 2020-07-07 — — CN disclosed
CN-105900013-B Active light-sensitive or radiation-sensitive resin composition and film 富士胶片株式会社 2019-12-24 — — CN disclosed
US-10394127-B2 Pattern forming method and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2019-08-27 — — US disclosed
EP-2579902-B2 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS PIRAMAL IMAGING SA (CH) 2019-08-14 — — EP disclosed
EP-3106920-B1 ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE RESIN COMPOSITION, ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE FILM, MASK BLANK PROVIDED WITH ACTIVE LIGHT SENSITIVE OR RADIATION SENSITIVE FILM, PHOTOMASK, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORP (JP) 2019-07-10 — — EP disclosed
US-10120281-B2 Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, mask blank provided with actinic ray-sensitive or radiation-sensitive film, photomask, pattern forming method, method for manufacturing electronic device, and electronic device FUJIFILM CORPORATION (JP) 2018-11-06 — — US disclosed
US-20180201989-A1 OXIDANT AND USE THEREOF THE UNIVERSITY OF TOKYO (JP) 2018-07-19 — — US disclosed
WO-2011151281-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-08 — — WO disclosed
WO-2011151282-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGAND BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-08 — — WO disclosed
WO-2011151273-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-08 — — WO disclosed
WO-2011151283-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-08 — — WO disclosed
US-20110102528-A1 COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND INKJET RECORDING METHOD FUJIFILM CORPORATION (JP) 2011-05-05 — — US disclosed
US-20090253881-A1 POLYMERIZABLE COMPOUND FOR PHOTORESIST, POLYMER THEREOF, AND PHOTORESIST COMPOSITION CONTAINING SUCH POLYMER IDEMITSU KOSAN CO., LTD. (JP) 2009-10-08 — — US disclosed
EP-1882705-A1 POLYMERIZABLE COMPOUND FOR PHOTORESIST, POLYMER THEREOF, AND PHOTORESIST COMPOSITION CONTAINING SUCH POLYMER IDEMITSU KOSAN CO., LTD. (JP) 2008-01-30 — — EP disclosed
CN-1543455-A 3-phenoxy-4-pyridazinol derivatives and herbicidal compositions containing the same 三共农业株式会社 2004-11-03 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110102528-A1 COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND INKJET RECORDING METHOD ARFGAP1, FRG1, RHOA CA2 1775/4885CA1 112/4885CA9 289/4885
US-20140012032-A1 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS APP, APBA1, BACE1 CA2 3808/4885CA1 1491/4885CA9 2733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback